Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

Does not reuse the syringe for insulin application

Does not reuse needles for insulin application Patients will be given quantity of needles for use during the study period according to the allocated group and a collector for sharps descarpack to collect the used syringes and needles. Initially, all patients will be instructed on the indication and importance of insulin use, aspects of conservation, preparation and administration, reviewing the dose aspirated in the syringe. They will also be instructed in relation to the use of the collector for sharps. Patients will also receive the booklet specially designed for this registry where they must indicate the number of hematomas, bruises, lipodystrophies, or inflammation that they identify whenever they occur. This booklet will be given to the team of researchers at each visit (monthly), who will review the records with the patient and guide them for subsequent completion.

DEVICE

Uses the syringe for insulin delivery five times

Uses the needles for insulin application five times. Patients will be given quantity of needles for use during the study period according to the allocated group and a collector for sharps descarpack to collect the used syringes and needles. Initially, all patients will be instructed on the indication and importance of insulin use, aspects of conservation, preparation and administration, reviewing the dose aspirated in the syringe. They will also be instructed in relation to the use of the collector for sharps. Patients will also receive the booklet specially designed for this registry where they must indicate the number of hematomas, lipodystrophies, or inflammation that they identify whenever they occur. This booklet will be given to the team of researchers at each visit (monthly), and they will review the records with the patient and guide them for subsequent completion.

Trial Locations (1)

90410-000

Gabriela Berlanda, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT05407233 - Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter